QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Oncolytics Biotech (ONC) News Today

C$1.44
+0.01 (+0.70%)
(As of 04:22 PM ET)
SourceHeadline
ca.finance.yahoo.com logoStocks in play: Oncolytics Biotech® Inc.
ca.finance.yahoo.com - April 11 at 3:56 PM
finance.yahoo.com logoOncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
finance.yahoo.com - April 11 at 8:38 AM
markets.businessinsider.com logoTransgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
markets.businessinsider.com - April 10 at 6:01 PM
marketbeat.com logoOncolytics Biotech (TSE:ONC) Trading Up 10.7%
marketbeat.com - April 4 at 10:46 AM
theglobeandmail.com logoClosing Bell: Oncolytics Bio down on Friday (ONC)
theglobeandmail.com - March 16 at 10:14 AM
msn.com logoFutures Retreat Sharply
msn.com - March 11 at 4:05 PM
finanznachrichten.de logoOncolytics Biotech Inc.: Oncolytics Biotech Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
finanznachrichten.de - March 6 at 4:39 PM
finanznachrichten.de logoEcon Corp Services DBA Investorideas.com: Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
finanznachrichten.de - March 6 at 4:39 PM
benzinga.com logoA Preview Of Oncolytics Biotech's Earnings
benzinga.com - March 6 at 4:39 PM
marketbeat.com logoOncolytics Biotech (ONC) Set to Announce Earnings on Thursday
marketbeat.com - March 5 at 10:10 AM
morningstar.com logoOncolytics Biotech Inc ONC
morningstar.com - March 2 at 6:22 PM
markets.businessinsider.com logoReiterating Buy Rating: Expanding Potential of Pelareorep in Oncolytics Biotech’s Pipeline
markets.businessinsider.com - February 15 at 9:24 AM
finance.yahoo.com logoCancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
finance.yahoo.com - February 15 at 9:24 AM
theglobeandmail.com logoAnal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
theglobeandmail.com - February 14 at 2:36 PM
finanznachrichten.de logoUSA News Group: Pancreatic Cancer Treatments Poised for Major Advances in 2024
finanznachrichten.de - February 7 at 11:03 AM
marketbeat.com logoOncolytics Biotech (TSE:ONC) Trading Down 7.1%
marketbeat.com - February 6 at 2:25 PM
finance.yahoo.com logoKaliVir Announces Opening of GMP Cleanroom Facility, Increasing Manufacturing Capacity for Oncolytic Viruses
finance.yahoo.com - January 31 at 8:47 PM
benzinga.com logoOncolytics Biotech Stock (NASDAQ:ONCY), Analyst Ratings, Price Targets, Predictions
benzinga.com - January 6 at 3:30 PM
markets.businessinsider.com logoJonesTrading Keeps Their Hold Rating on TRACON Pharmaceuticals (TCON)
markets.businessinsider.com - December 14 at 8:26 AM
finanznachrichten.de logoOncolytics Biotech Inc.: Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
finanznachrichten.de - December 7 at 8:30 AM
finance.yahoo.com logoOncolytics Provides Update on Pancreatic Cancer Program for Pelareorep
finance.yahoo.com - November 9 at 7:48 AM
benzinga.com logoOncolytics Biotech's Earnings Outlook
benzinga.com - November 3 at 6:37 PM
finanznachrichten.de logoOncolytics Biotech Inc.: Oncolytics Biotech Reports Third Quarter 2023 Financial Results and Operational Highlights
finanznachrichten.de - November 3 at 1:36 PM
finanznachrichten.de logoOncolytics Biotech Inc.: Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
finanznachrichten.de - November 3 at 1:36 PM
finance.yahoo.com logoOncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
finance.yahoo.com - November 3 at 1:36 PM
msn.com logoOncolytics Biotech GAAP EPS of -$0.14 misses by $0.06
msn.com - November 3 at 8:36 AM
finance.yahoo.com logoOncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
finance.yahoo.com - November 3 at 8:36 AM
marketwatch.com logoOncolytics Shares Rise 9.3% as Data Presented From Pancreatic Cancer Study
marketwatch.com - October 23 at 8:38 PM
finanznachrichten.de logoUSA News Group: Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
finanznachrichten.de - October 20 at 12:48 PM
finanznachrichten.de logoOncolytics Biotech® Inc.: Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
finanznachrichten.de - October 20 at 7:47 AM
ca.finance.yahoo.com logoStocks in play: Oncolytics Biotech, Inc.
ca.finance.yahoo.com - September 28 at 7:00 PM
baystreet.ca logoPioneering the Path to Cure Cancer: 2023's Biotech Innovations
baystreet.ca - September 22 at 10:07 AM
finanznachrichten.de logoUSA News Group: On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
finanznachrichten.de - September 20 at 3:23 PM
msn.com logoOncolytics Biotech: Is The Early Data Really That Good?
msn.com - September 13 at 3:30 PM
finance.yahoo.com logo3 Under-$20 Stocks to Buy for Explosive Returns
finance.yahoo.com - August 29 at 1:43 AM
markets.businessinsider.com logoJonesTrading downgrades TRACON Pharmaceuticals (TCON) to a Hold
markets.businessinsider.com - August 18 at 6:12 PM
finanznachrichten.de logoOncolytics Biotech® Inc.: Oncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights
finanznachrichten.de - August 14 at 9:57 AM
msn.com logoOncolytics Biotech GAAP EPS of -C$0.12
msn.com - August 14 at 9:57 AM
finance.yahoo.com logoOncolytics Biotech® Reports Second Quarter 2023 Financial Results and Operational Highlights
finance.yahoo.com - August 14 at 9:57 AM
markets.businessinsider.com logoJonesTrading Remains a Buy on Cassava Sciences (SAVA)
markets.businessinsider.com - August 3 at 6:22 PM
marketwatch.com logoOncolytics Biotech Stock Down 15% on Deal for Discounted Offering
marketwatch.com - July 31 at 12:55 PM
finanznachrichten.de logoOncolytics Biotech® Inc.: Oncolytics Biotech® Announces US$15 Million Bought Deal Offering of Units
finanznachrichten.de - July 31 at 7:55 AM
finance.yahoo.com logoOncolytics Biotech® Announces US$15 Million Bought Deal Offering of Units
finance.yahoo.com - July 31 at 7:55 AM
markets.businessinsider.com logoH.C. Wainwright Sticks to Their Buy Rating for Gossamer Bio (GOSS)
markets.businessinsider.com - July 26 at 4:51 PM
theglobeandmail.com logoOncolytics Biotech: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (ONC)
theglobeandmail.com - July 20 at 10:17 AM
benzinga.com logoHC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $15 Price Target
benzinga.com - June 29 at 2:00 PM
msn.com logoWhat’s Driving Oncolytics Shares to The Moon?
msn.com - June 26 at 7:25 PM
markets.businessinsider.com logoOncolytics Biotech (ONCY) Receives a Buy from Maxim Group
markets.businessinsider.com - June 24 at 12:34 PM
markets.businessinsider.com logoOncolytics Biotech (ONCY) Gets a Buy from Canaccord Genuity
markets.businessinsider.com - June 23 at 2:55 PM
msn.com logoOncolytics Biotech’s stock soars 25% after pelareorep is selected for inclusion in late-stage pancreatic cancer trial
msn.com - June 22 at 11:21 PM
Get Oncolytics Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter.

Secret Bull Market Starts in This Unusual Sector (Ad)

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here. 

ONC Media Mentions By Week

ONC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONC
News Sentiment

0.42

0.52

Average
Medical
News Sentiment

ONC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONC Articles
This Week

0

1

ONC Articles
Average Week

Get Oncolytics Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (TSE:ONC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners